https://www.catswannabecats.com/members/lutecicada8/activity/ Activity feed for Tuttle Lausen. Tue, 30 Jun 2026 07:59:13 -0400 https://buddypress.org/?v=7.2.0 en-CA 30 hourly 2 92adefdef6e034ff07353dfa1665e2ca https://www.catswannabecats.com/activity/p/23462/ Sun, 08 Jun 2025 09:15:43 -0400 The developmental trajectories of soccer players’ EFs follow the general populations’ despite long-term exposure to soccer-specific training and game play. This brings into question the relationship between high-level experience and EFs and renders including EFs in talent identification questionable.Social interactions are theorized to inform…[Read more]

]]> 0 35ae92dacf58f72c45d2089257d6d7e5 https://www.catswannabecats.com/activity/p/23380/ Sun, 08 Jun 2025 09:02:30 -0400 The developmental trajectories of soccer players’ EFs follow the general populations’ despite long-term exposure to soccer-specific training and game play. This brings into question the relationship between high-level experience and EFs and renders including EFs in talent identification questionable.Social interactions are theorized to inform…[Read more]

]]> 0 816fe44f6323122cbf0d0dc66815e6c1 https://www.catswannabecats.com/activity/p/12008/ Sun, 01 Jun 2025 08:35:37 -0400 Background and objective Dengue viral infections are a standout amongst the supreme critical mosquito-borne illnesses nowadays. They create problems like dengue fever (DF), dengue stun disorder (DSS) and dengue hemorrhagic fever (DHF). Lately, the frequency of DHF has expanded considerably. Dengue may be caused by one of serotypes DEN-1 to DEN-4.…[Read more]

]]> 0 88fb672068788d8caadeb6b1bd016fa6 https://www.catswannabecats.com/activity/p/2203/ Sat, 31 May 2025 08:00:09 -0400 Ibrutinib is a BTK/ITK inhibitor with efficacy for the treatment of various lymphoid cancers, including CLL. Considering that innate and adaptative immune defects are a dominant feature of CLL patients, we evaluated whether in vitro ibrutinib affects the survival and function of neutrophils and γδ T cells, key players of the early immune r…[Read more]

]]> 0 067d5b1c2a32c81890c232b68ef142c1 https://www.catswannabecats.com/activity/p/2094/ Sat, 31 May 2025 07:51:59 -0400 Ibrutinib is a BTK/ITK inhibitor with efficacy for the treatment of various lymphoid cancers, including CLL. Considering that innate and adaptative immune defects are a dominant feature of CLL patients, we evaluated whether in vitro ibrutinib affects the survival and function of neutrophils and γδ T cells, key players of the early immune r…[Read more]

]]> 0 5b46c4cfe5d58fb1a7e0e79f6cf18781 https://www.catswannabecats.com/activity/p/1984/ Sat, 31 May 2025 07:44:04 -0400 Ibrutinib is a BTK/ITK inhibitor with efficacy for the treatment of various lymphoid cancers, including CLL. Considering that innate and adaptative immune defects are a dominant feature of CLL patients, we evaluated whether in vitro ibrutinib affects the survival and function of neutrophils and γδ T cells, key players of the early immune r…[Read more]

]]> 0 a4ea620447f52decfbeac7f7f942db49 https://www.catswannabecats.com/activity/p/1874/ Sat, 31 May 2025 07:37:22 -0400 Ibrutinib is a BTK/ITK inhibitor with efficacy for the treatment of various lymphoid cancers, including CLL. Considering that innate and adaptative immune defects are a dominant feature of CLL patients, we evaluated whether in vitro ibrutinib affects the survival and function of neutrophils and γδ T cells, key players of the early immune r…[Read more]

]]> 0 ff77ff4f839c3a337c20c8bb8e94f7bd https://www.catswannabecats.com/activity/p/1710/ Sat, 31 May 2025 07:26:47 -0400 0